Get Started

XGN

Exagen (XGN)

Exagen Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:XGN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Date	Time	Source	Headline	Symbol	Company
04/28/2022	4:19PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:XGN	Exagen Inc
04/25/2022	4:05PM	GlobeNewswire Inc.	Exagen to Announce First Quarter 2022 Financial Results on May 11, 2022	NASDAQ:XGN	Exagen Inc
04/20/2022	4:05PM	GlobeNewswire Inc.	Exagen Inc. to Participate in Investor Summit Group’s Q2 Conference	NASDAQ:XGN	Exagen Inc
03/30/2022	8:25AM	GlobeNewswire Inc.	Exagen Inc. Expands In-Network Access with Evolutions Healthcare Systems	NASDAQ:XGN	Exagen Inc
03/22/2022	5:22PM	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:XGN	Exagen Inc
03/22/2022	4:06PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:XGN	Exagen Inc
03/22/2022	4:06PM	GlobeNewswire Inc.	Exagen Inc. Expands In-Network Benefit with Additional 22.7 Million Lives	NASDAQ:XGN	Exagen Inc
03/22/2022	4:05PM	GlobeNewswire Inc.	Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results	NASDAQ:XGN	Exagen Inc
03/16/2022	4:05PM	GlobeNewswire Inc.	Exagen Announces New Rheumatoid Arthritis Scientific Advisory Board	NASDAQ:XGN	Exagen Inc
03/09/2022	4:05PM	GlobeNewswire Inc.	Exagen Inc. to Participate in the 2022 KeyBanc Capital Markets Life Sciences and MedTech Investor Forum	NASDAQ:XGN	Exagen Inc
03/08/2022	4:05PM	GlobeNewswire Inc.	Exagen to Announce Fourth Quarter and Full Year Financial Results on March 22, 2022	NASDAQ:XGN	Exagen Inc
03/02/2022	4:44PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XGN	Exagen Inc
03/02/2022	4:44PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XGN	Exagen Inc
03/02/2022	4:43PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XGN	Exagen Inc
02/15/2022	9:49AM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:XGN	Exagen Inc
02/14/2022	1:10PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:XGN	Exagen Inc
02/14/2022	6:14AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:XGN	Exagen Inc
02/11/2022	2:10PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:XGN	Exagen Inc
02/10/2022	4:17PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:XGN	Exagen Inc
02/08/2022	4:25PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XGN	Exagen Inc
02/08/2022	4:25PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XGN	Exagen Inc
02/08/2022	4:23PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XGN	Exagen Inc
02/08/2022	4:14PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:XGN	Exagen Inc
02/02/2022	4:05PM	GlobeNewswire Inc.	Exagen Inc. to Participate in the 2022 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference	NASDAQ:XGN	Exagen Inc
01/20/2022	10:47AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:XGN	Exagen Inc
01/10/2022	8:26AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:XGN	Exagen Inc
01/09/2022	12:00PM	GlobeNewswire Inc.	Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection	NASDAQ:XGN	Exagen Inc
12/27/2021	6:01AM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:XGN	Exagen Inc
12/17/2021	3:58PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:XGN	Exagen Inc
11/17/2021	4:05PM	GlobeNewswire Inc.	Exagen Inc. to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference	NASDAQ:XGN	Exagen Inc